NLRP3 and polycystic ovary syndrome: Pioglitazone and metformin dual therapy could mitigate the psychological distress of PCOS patients by reducing NLRP3 inflammasome activation (112, 113), while plumbagin has been found to reduce pyroptosis of GCs.